-- 加拿大央行将“严阵以待”,但这不仅是为了应对高通胀,也是为了应对经济增长乏力和过度闲置产能。加拿大帝国商业银行(CIBC)在周三的政策声明后表示,这两种风险共同作用,导致利率维持在2.25%不变。 该行指出,鉴于未来前景不明朗,将政策利率维持在2.25%并不令人意外。 CIBC表示,加拿大央行假设油价将在2027年年中逐步回落至每桶75美元,这仍将推高短期通胀,但对经济增长前景的影响与此前预测基本一致,即经济闲置产能的消除进程将非常缓慢。 该行表示,今年和2027年的国内生产总值(GDP)增速略有加快,但潜在产出范围也相应上调,这意味着经济闲置产能的收窄程度不会改变。加拿大央行认为,目前“几乎没有迹象”表明能源价格上涨会波及核心通胀,但会密切关注,并“不会让能源价格上涨演变为持续性通胀”。 如果这听起来鹰派,值得注意的是,加拿大央行并不认为这种情况会发生。该行预测通胀率将飙升至3%,但会在明年初回落至2%的目标水平。加拿大帝国商业银行(CIBC)也持相同观点。加拿大央行表示,虽然可能需要调整政策利率,但这些调整“预计幅度不大”。 这听起来像是加拿大央行认为可以“维持利率不变”,因为它列举了两种可能需要降息或加息的情况:贸易限制,例如,如果能源价格引发更广泛的通胀。
Related Articles
Mizuho Securities Raises Price Target on Apellis Pharmaceuticals to $41 From $20, Maintains Neutral Rating
Apellis Pharmaceuticals (APLS) has an average rating of hold and mean price target of $40.82, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $40.95, Change: $-0.05, Percent Change: -0.11%
Mizuho Securities Downgrades Terns Pharmaceuticals to Neutral From Outperform, Trims Price Target to $53 From $54
Terns Pharmaceuticals (TERN) has an average rating of hold and mean price target of $53, according to analysts polled by FactSet.
Research Alert: CFRA Reiterates Buy Opinion On Shares Of Booking Holdings Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month target price by $8 to $196, 19x our 2026 EPS estimate (unchanged) and a discount to its 23x five-year average forward multiple, reflecting geopolitical risks. We lower our 2026 EPS to $10.33 from $10.74 and 2027's to $11.58 from $12.07, primarily reflecting lower gross bookings growth from the Middle East conflict. We maintain our Buy opinion as shares are undervalued given long-term competitive strengths and temporary geopolitical headwinds. The company's Connected Trip platform and Genius loyalty program are supporting higher-margin direct bookings, suggesting AI initiatives are strengthening consumer engagement rather than disintermediating the platform. Strong free cash flow supports future shareholder returns, including $3.6 billion in Q1 buybacks. While the Middle East conflict will impact Q2 bookings, BKNG has a history of seeing travel rebound following geopolitical or economic disruptions. U.S. room night growth accelerated in Q1 to a low-teens range, providing near-term momentum.